RMS Medical Devices Announces Strategic Commercial Partnership with Avicenna.AI in the Benelux Region
Belgium — March, 2025 – RMS Medical Devices, a leader in innovative medical technologies, is excited to announce a strategic commercial partnership with Avicenna.AI, a global pioneer in artificial intelligence (AI) solutions for medical imaging. This partnership aims to bring cutting-edge AI-powered diagnostic tools to healthcare providers in Belgium, the Netherlands, and Luxembourg (Benelux), enhancing […]
Viz.ai Integrates Avicenna.AI’s Tools for ASPECTS Stroke Severity Assessment and Incidental Pulmonary Embolism into Viz.ai One Platform
SAN FRANCISCO – December 16, 2024 –Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, and Avicenna.AI, a leading provider of AI-based medical imaging solutions, today announced that Viz.ai is integrating Avicenna.AI’s CINA-iPE and CINA-ASPECTS tools into the Viz.ai One™ platform. The combination of Avicenna’s two AI-based algorithms with Viz.ai’s care coordination capabilities […]
Integrating Avicenna.AI into the teleradiology workflow: Feedback from TIM smooth integration into clinical practice
Our teleradiology workflow is based on systematic, near real-time analysis using Avicenna.AI’s tools for analyzing CT scan exams performed in our partner establishments, in both scheduled and emergency workflows. In typically scheduled workflows, the radiologist’s interpretation can occur retrospectively, even after the patient has left the department. AI analysis serves as an initial assessment tool, […]
TIM & AVICENNA.AI announce strategic partnership to strengthen medical imaging in France
Nantes, Loire-Atlantique, le 25 septembre 2024 TIM, a major player in teleradiology in mainland France and the French overseas territories, and registered with the Resah for scheduled and emergency PDS/CDS (day/night) activities, has announced the strengthening of its strategic partnership with Avicenna.AI, a leader in the development of artificial intelligence solutions dedicated to medical imaging. […]
Avicenna.AI secures two FDA clearances for Stroke Assessment and opportunistic PE
Avicenna.AI receives approval for algorithms enabling incidental detection of pulmonary embolism and automatic assessment of stroke severity.
Blackford integrates CINA-iPE for opportunistic pulmonary embolism detection
La Ciotat, FRANCE – February 15, 2024 – Avicenna.AI, a French medical imaging AI specialist, is proud to announce a strategic partnership with AI platform pioneers Blackford to integrate its CINA-iPE, a CE-marked solution, into the Blackford AI Platform. This collaboration represents a significant step forward in the field of healthcare AI, offering healthcare professionals […]
ConcertAI’s TeraRecon partners with Avicenna.AI for AI-driven chest care coordination.
CAMBRIDGE, Mass., 01/11/2023 – ConcertAI’s TeraRecon, a leader in advanced visualization and AI Clinical SaaS, is pleased to announce an expanded collaboration with Avicenna.AI, a specialist in medical imaging AI. Together, they will provide global solutions that leverage artificial intelligence to enhance care coordination and improve patient triage for individuals afflicted with pulmonary embolism (PE) […]
ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
Medical imaging AI companies collaborate to offer CINA-iPE on TeraRecon’s Eureka Clinical AI platform. Cambridge, Mass., March 13, 2023 – ConcertAI’s TeraRecon, the advanced visualization and AI Clinical SaaS category leader, today announced a partnership to offer medical imaging AI specialist Avicenna.AI‘s CINA-iPE solution detecting the presence of incidental pulmonary embolisms as part of TeraRecon’s Eureka Clinical […]
Incepto Collaborates with Avicenna.AI to improve stroke management in Europe
Paris, France. February 13th, 2023 – Incepto, distributor, and co-creator of artificial intelligence (AI) solutions applied to medical imaging, signs a partnership with Avicenna.AI, developer of AI solutions for Radiology, and enriches its platform with new solutions for neurovascular pathologies such as stroke. All of these solutions are CE-cleared, and two are FDA marked. These […]
Avicenna.AI partners with CARPL.ai on AI to detect life-threatening conditions
Avicenna.AI’s advanced AI detection tools are now available via the CARPL platform. Marseille, FRANCE – November 22, 2022 – Medical imaging AI specialist Avicenna.AI todayannounced a distribution agreement with CARPL.ai, a technology platform that enables service provider-oriented testing, validation and deployment of AI applications to healthcare providers. As the number of AI applications coming into […]